IL-18-induced CD83+CCR7+ NK helper cells - Wikidata - wikimedia - TriplyDB

IL-18-induced CD83+CCR7+ NK helper cells

IL-18-induced CD83+CCR7+ NK helper cells

http://www.wikidata.org/entity/Q36403560

about

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?The IL-1 cytokine family and its role in inflammation and fibrosis in the lung The role of NK cells in HIV-1 protection: autologous, allogeneic or both?Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology Regulation of immune responses by prostaglandin E2 Tumor microenvironment: regulatory cells and immunosuppressive cytokines An NK Cell Perforin Response Elicited via IL-18 Controls Mucosal Inflammation Kinetics during Salmonella Gut Infection Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor Features of Memory-Like and PD-1(+) Human NK Cell Subsets Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma.CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression.Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues.Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response The interleukin-1 family: back to the future The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes.Chronic alcohol consumption decreases the percentage and number of NK cells in the peripheral lymph nodes and exacerbates B16BL6 melanoma metastasis into the draining lymph nodes Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.Blood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantation Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting.The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.Regulation of development of CD56 bright CD11c + NK-like cells with helper function by IL-18.B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape.Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells.IL-2 and IL-18 attenuation of airway hyperresponsiveness requires STAT4, IFN-gamma, and natural killer cells Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15.Inflammatory spleen monocytes can upregulate CD11c expression without converting into dendritic cells.Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7.Role of natural killer cell function in dendritic cell-based vaccines.Migration and Tissue Tropism of Innate Lymphoid Cells.Manifestations of immune tolerance in the human female reproductive tract.Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions.

P2860

Q26746478-8BBA0C82-CED1-44E7-8E77-C800FCD6BAAC Q26752849-2E64091B-A7DA-472D-B22F-E56481821719 Q26753146-6A722000-49E9-43EB-9D75-F1F907F66753 Q26765345-693156A2-55AC-43CE-AFA7-63CF714111AE Q26825075-22934EA7-0BD0-4994-987C-485DF6BE9EF7 Q26849305-DC2F3A55-DCD7-4FEB-9AB2-49119FFF91A4 Q27007772-C0D5B59D-8855-4993-B44F-9BBF0ACE0735 Q27313075-02A3F0EB-DE8F-40A9-8585-8B49BFECAFF3 Q28067468-7E41CA7B-92DF-4535-B2B9-54880FDA6CC7 Q28073988-6FD0E042-4FA0-46AA-AB02-8FEF9E5BB94A Q28079140-B0309380-45C0-4259-AE86-1368B21F5F6D Q33319277-469713C4-8690-477D-BBF9-A4A3F224191D Q33896743-41CE067A-E85F-44FB-8052-F88B20E73EC3 Q33911213-5E53481C-7424-4E62-9D88-92FE44C75B5A Q33978035-BE3C39AE-4E3F-4223-816C-5859E7B368CF Q34009362-934B998B-CEEF-4364-8567-3A0DA83E9FDE Q34022257-4BEAE7BA-5627-4BE6-9D69-2C4FE4952561 Q34087961-E832C3DF-6206-4E2D-9717-82CD80D47001 Q34130226-A6C9951E-FB3D-4FCD-9E4C-C9F04ED0696C Q34194706-01A896B9-8A29-4D99-8767-6BC4E651626A Q34314259-29F635DB-4F04-45CF-99FF-439722843BB6 Q34391415-2570CCA1-26DD-4B25-90C3-788BECF08BB8 Q34411026-E7C0625F-53A1-4BB0-83FB-21BEB9F8490F Q34425143-3850C68F-13A4-4922-B286-3765942C6DAB Q34467270-21E79626-5807-4F61-88ED-B337B6A682DB Q34618829-7F47F753-59AF-449B-9D97-54328678DEBB Q34672927-B795F301-D2E1-4EE9-8D59-580934CB120D Q34683623-761BC012-660E-4449-BF2F-00C208BE1429 Q34989042-4B19F7D2-4D0F-4414-BB65-1FAB8B4E3068 Q35077632-F428F2CB-68F5-4DA5-AA67-B6C0FB29872A Q35798978-C24B4843-5320-40FC-B2FE-163594919920 Q35806714-4023F647-ECF8-43DA-B681-52880F6778EE Q35855291-A38F52D2-10AE-4A54-960E-704FAA1F455D Q35883106-1AA1F6BD-0A5B-47B9-8E61-30944FEA0A3B Q36126087-587DC71A-DD02-4126-921E-3CC0E4776088 Q36163212-80944EFD-F263-4220-A9E5-672E252CD3DA Q36383802-79C98F53-BB86-4AE6-84F6-AD0A904032FB Q36554706-93FB0290-42FB-4E9B-9835-A33CC56D9BA9 Q36606027-554D767E-D518-4DC3-A257-A6AE2D136788 Q36675441-326CF446-648E-4740-AA6A-AAAEE4F66AF1

P2860

IL-18-induced CD83+CCR7+ NK helper cells

http://www.wikidata.org/entity/Q36403560

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

IL-18-induced CD83+CCR7+ NK helper cells

@ast

IL-18-induced CD83+CCR7+ NK helper cells

@en

type

label

IL-18-induced CD83+CCR7+ NK helper cells

@ast

IL-18-induced CD83+CCR7+ NK helper cells

@en

prefLabel

IL-18-induced CD83+CCR7+ NK helper cells

@ast

IL-18-induced CD83+CCR7+ NK helper cells

@en

P1433

Q36403560-3EBA4BE9-7A67-48F7-BAC0-D694F5B3ABD7

P1476

Q36403560-53C3A6EB-F99B-46B3-8795-270F2A914849

P2093

Q36403560-452ADAA4-46BE-4D82-816D-C62DE996CE73

Q36403560-502F8ECD-56ED-4E6D-BB9D-11F455C7889F

Q36403560-95A71E47-BC65-4287-9E9C-EF27114444D9

Q36403560-95CCAB9A-DFA9-41FA-B243-88C139866538

Q36403560-E0107CE3-DA46-4EFA-BA14-D5403BA324C1

Q36403560-F7BD5666-AD37-4BB6-9076-50BBD77F5142

P2860

Q36403560-04B358B9-26AA-49F4-8B40-9ADB86D85E8B

Q36403560-098E3852-C6E8-40E8-AE16-6CA5DF48A10C

Q36403560-0BD8CE47-2637-41B5-872C-23B85BEFB664

Q36403560-0BF4E3D7-1A10-47C0-9000-3D914D1FFBD6

Q36403560-0D3D8EAA-DE43-48D6-901E-F0347F99B84F

Q36403560-0D442C6E-9353-4AED-8933-C52A5B3671A7

Q36403560-10AF08E4-7AA0-4AD1-93AD-7DDF3C2B7BAE

Q36403560-11232328-A077-4C97-99F0-CED3DB9CDFE3

Q36403560-1D3D69FA-1E63-429A-A2CB-1B25D18E366D

Q36403560-2252A855-E35A-43D7-B3A1-B4C6FB45B980

P304

Q36403560-6B983F18-8FDE-4AC2-A274-0AE1ED77353C

P31

Q36403560-767C98C0-F091-4F53-9683-B15B9B58746C

P356

Q36403560-79D2E4E0-8A17-4E4E-BF2A-314D47214D8B

P407

Q36403560-CD724B47-6F0F-4C36-B51D-9E65893B97DD

P433

Q36403560-417B3639-879F-4590-B2ED-877F9EFC5BC9

P478

Q36403560-19E174C4-72BA-4821-9436-1707264852FC

P50

Q36403560-94EB4230-D28E-4412-ACAC-DA68F86D69E4

P577

Q36403560-800303A4-96A1-439A-9D15-0485EB9AB785

P5875

Q36403560-09230FFB-29D2-4772-82BB-D4A33F20F7C0

P698

Q36403560-A637C8CA-EF0F-4003-9CB1-1C92C2FE996F

P932

Q36403560-CEDA06A0-3427-41C5-81B4-7AA62E86B50C

P356

P1433

Journal of Experimental Medicine

P1476

IL-18-induced CD83+CCR7+ NK helper cells

@en

P2093

Hongmei Shen

http://www.w3.org/2001/XMLSchema#string

John M Kirkwood

http://www.w3.org/2001/XMLSchema#string

Pawel Kalinski

http://www.w3.org/2001/XMLSchema#string

Ronald B Herberman

http://www.w3.org/2001/XMLSchema#string

Sean M Alber

http://www.w3.org/2001/XMLSchema#string

Simon C Watkins

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors

A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Cloning of a new cytokine that induces IFN-gamma production by T cells

Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke

Interleukin-12 and the regulation of innate resistance and adaptive immunity

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.

P304

941-953

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20050128

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P50

Robbie B. Mailliard

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7561113

http://www.w3.org/2001/XMLSchema#string

P698

16203865

http://www.w3.org/2001/XMLSchema#string

P932

2213172

http://www.w3.org/2001/XMLSchema#string